← Open Payments lookup

CARRIE KRAMER: Open Payments

NPI 1881389328 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,022 in 54 payments from 11 companies in 2025. Trend: 2023 $1,240 · 2024 $2,411 · 2025 $1,022

Food & beverage: $1,022
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$220
Teva Pharmaceuticals USA, Inc.10$214
ABBVIE INC.8$138
Otsuka America Pharmaceutical, Inc.4$109
Alkermes, Inc.3$82
Vanda Pharmaceuticals Inc.2$78
Neurocrine BioSciences, Inc.3$75
E.R. Squibb & Sons, L.L.C.2$40
Takeda Pharmaceuticals U.S.A., Inc.2$27
Biogen, Inc.1$22

Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, REXULTI, ARISTADA, HETLIOZ, INGREZZA, UZEDY.

Industry payments across NY — which companies pay providers there.